EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Formulation and Evaluation of VCAM-1-Targeted Methotrexate Lipid Nanoparticles for Rheumatoid Arthritis Therapy

Ren Na, Jianmei Jing, Hua Yang, Ye Li, Xiaofeng Yuan, Xue Sun, Jiangfan Han, Jiajun Wang, Zhenhua Tong, Guangbin He, Weiliang Ye iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s532163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Ren Na und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, People's Republic of China. Hauptthemen laut MEDLINE: Methotrexate, Arthritis, Rheumatoid, Nanoparticles, Vascular Cell Adhesion Molecule-1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateArthritis, RheumatoidNanoparticlesVascular Cell Adhesion Molecule-1Antirheumatic AgentsAnimalsHumansHuman Umbilical Vein Endothelial CellsRatsArthritis, ExperimentalRats, Sprague-DawleyParticle SizeMaleLipidsCell MovementLiposomes

Stichwörter der Autor:innen

PVCAM-1lipid nanoparticlesmethotrexaterheumatoid arthritissynovial fibroblasts

Substanzen

MethotrexateVascular Cell Adhesion Molecule-1Antirheumatic AgentsLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Department of Ultrasound Diagnosis, Xijing Hospital, Fourth Military Medical University, Xi'an, 710038, People's Republic of China.
  • Department of Medical Affairs, No. 968 Hospital of Chinese People's Liberation Army, Jinzhou, 121000, People's Republic of China.
  • Department of Pharmacy, General Hospital of Northern Theater Command, Shenyang, 110016, People's Republic of China.

ORCID-Profile: Weiliang Ye

Zitieren

APA

Na, R., Jing, J., Yang, H., Li, Y., Yuan, X., Sun, X., Han, J., Wang, J., Tong, Z., He, G., & Ye, W. (2025). Formulation and Evaluation of VCAM-1-Targeted Methotrexate Lipid Nanoparticles for Rheumatoid Arthritis Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s532163

Vancouver

Na R, Jing J, Yang H, Li Y, Yuan X, Sun X, et al. Formulation and Evaluation of VCAM-1-Targeted Methotrexate Lipid Nanoparticles for Rheumatoid Arthritis Therapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s532163

BibTeX
@article{Na2025,
  author = {Na, Ren and Jing, Jianmei and Yang, Hua and Li, Ye and Yuan, Xiaofeng and Sun, Xue and Han, Jiangfan and Wang, Jiajun and Tong, Zhenhua and He, Guangbin and Ye, Weiliang},
  title = {Formulation and Evaluation of VCAM-1-Targeted Methotrexate Lipid Nanoparticles for Rheumatoid Arthritis Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s532163}
}
Kostenlos starten →